Login Register Cart 0
Generic placeholder image

Current Aging Science

Editor-in-Chief

ISSN (Print): 1874-6098
ISSN (Online): 1874-6128

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prevalence of COVID-19 Among 8000 Patients at a Hospitalized and Mortality in Old Age

Author(s): Maria Regina Pereira de Godoy, Maria Lucia Machado Salomão, Flavia Queiroz and Jose Maria Pereira de Godoy*

Volume 17, Issue 2, 2024

Published on: 25 January, 2024

Page: [109 - 112] Pages: 4

DOI: 10.2174/1874609816666230525124934

Price: $65

Abstract

Background: COVID-19 created a general challenge to healthcare systems throughout the world and was an important cause of mortality.

Aim: The aim of the present study was to report the general evolution of patients with COVID-19 at a teaching hospital and analyze differences by age group and sex considering mortality rates in the years 2020 and 2021 among patients older than 60 years of age.

Methods: A cross-sectional study was conducted with patients hospitalized with a diagnosis of COVID-19 confirmed by RT-PCR at the São Jose do Rio Preto university hospital between March 2020 and March 2022. The patients were male and female patients, of varying ages belonging to the region of Sao Jose do Rio Preto, were accommodated in the wards or intensive care units (ICUs). Overall mortality was analyzed for the hospital as well as in the ICUs and wards. This analysis was performed separately in two years considering age group, sex, and main comorbidities in patients older than 60 years of age.

Results: A total of 8032 patients with COVID-19 were hospitalized between March 2020 and March 2022: 2866 patients with 658 deaths (22.92%) in 2020; 4324 patients with 1168 deaths (27.01%) in 2021; and 842 patients with 205 deaths (24.35 %) in 2022 up to the month of March. More than half (53.60%) of the patients were hospitalized in the ICUs and 46.39% were hospitalized in the wards. Differences in the mortality rate were found for the different age groups in the comparison of the years, with more deaths occurring among individuals up to 90 years of age in the second year (p <0.05). Men were affected more and had a higher mortality rate (p <0.0001). The main comorbidities were cardiovascular disease (70.93%), diabetes (37.76%), and obesity (23.68%).

Conclusion: The mortality rate of older people hospitalized with COVID-19 was higher than the average, it was higher in 2021 compared to 2020 and increased with age. Cardiovascular disease, diabetes, and obesity were the main comorbidities.

« Previous Next »
Graphical Abstract

[1]
Damayanthi HDWT, Prabani KIP, Weerasekara I. Factors associated for mortality of older people with COVID 19: A systematic review and meta-analysis. Gerontol Geriatr Med 2021; 7: 23337214211057392.
[http://dx.doi.org/10.1177/23337214211057392 ] [PMID: 34888405]
[2]
Tejada-Vera B, Kramarow E. COVID-19 mortality in adults aged 65 and over: United States, 2020. NCHS Data Brief 2022; (446): 1-8.
[http://dx.doi.org/10.15620/cdc:121320 ] [PMID: 36256450]
[3]
Ruiz-Huerta C, Canto MV, Ruiz C, et al. COVID-19 mortality in patients aged 80 and over residing in nursing homes—six pandemic waves: OCTA-COVID study. Int J Environ Res Public Health 2022; 19(19): 12019.
[http://dx.doi.org/10.3390/ijerph191912019 ] [PMID: 36231321]
[4]
Alves VP, Casemiro FG, Araujo BG, et al. Factors associated with mortality among elderly people in the COVID-19 pandemic (SARS-CoV-2): A systematic review and meta-analysis. Int J Environ Res Public Health 2021; 18(15): 8008.
[http://dx.doi.org/10.3390/ijerph18158008 ] [PMID: 34360301]
[5]
Nogales Vasconcelos AM, Ishitani L, Abreu DMX, França E. Covid adult mortality in Brazil: An analysis of multiple causes of death. Front Public Health 2022; 9: 788932.
[http://dx.doi.org/10.3389/fpubh.2021.788932 ] [PMID: 35111718]
[6]
Farshbafnadi M, Kamali Zonouzi S, Sabahi M, Dolatshahi M, Aarabi MH. Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors. Exp Gerontol 2021; 154: 111507.
[http://dx.doi.org/10.1016/j.exger.2021.111507 ] [PMID: 34352287]
[7]
Watson A, Wilkinson TMA. Respiratory viral infections in the elderly. Ther Adv Respir Dis 2021; 15.
[http://dx.doi.org/10.1177/1753466621995050 ] [PMID: 33749408]
[8]
Hungaro Cunha C, Yuri Sato D, Pereira de Godoy JM, et al. Mortality and deep vein thrombosis in the gamma variant of COVID-19 and lung injury. Vasc Health Risk Manag 2022; 18: 833-8.
[http://dx.doi.org/10.2147/VHRM.S367930 ] [PMID: 36353368]
[9]
Wirth R, Becker C, Djukic M, et al. COVID-19 in old age-The geriatric perspective. Z Gerontol Geriatr 2021; 54(2): 152-60.
[http://dx.doi.org/10.1007/s00391-021-01864-0 ] [PMID: 33595696]
[10]
Lee CJ, Woo W, Kim AY, et al. Clinical manifestations of COVID‐19 breakthrough infections: A systematic review and meta‐analysis. J Med Virol 2022; 94(9): 4234-45. Epub ahead of print
[http://dx.doi.org/10.1002/jmv.27871 ] [PMID: 35588301]
[11]
Vo AD, La J, Wu JTY, et al. Factors associated with severe COVID-19 among vaccinated adults treated in US veterans affairs hospitals. JAMA Netw Open 2022; 5(10): e2240037.
[http://dx.doi.org/10.1001/jamanetworkopen.2022.40037 ] [PMID: 36264571]
[12]
Pereira de Godoy MR, Machaso Salomão ML, Queiroz F, Furquim Siqueira N, Fernandez Cardoso L, Campos Indaló Saurin A. Evolution of mortality by age group in patients with COVID-19 above 60 years of age. Cureus 2021; 13(8): e17149.
[http://dx.doi.org/10.7759/cureus.17149 ] [PMID: 34430186]
[13]
Pereira de Godoy JM, Da Silva Russeff GJ, Hungaro Cunha C, Yuri Sato D, Franccini Del Frari Silva D, Guerreiro Godoy MF. Mortality and change in the prevalence of deep vein thrombosis associated With SARS-CoV-2 P.1 variant. Cureus 2022; 14(7): e26668.
[http://dx.doi.org/10.7759/cureus.26668 ] [PMID: 35949793]
[14]
Pereira de Godoy JM, Russeff GJS, Cunha CH, et al. Increased prevalence of deep vein thrombosis and mortality in patients with Covid-19 at a referral center in Brazil. Phlebology 2022; 37(1): 21-5.
[http://dx.doi.org/10.1177/02683555211041931 ] [PMID: 34494482]
[15]
Agrawal U, Bedston S, McCowan C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet 2022; 400(10360): 1305-20.
[http://dx.doi.org/10.1016/S0140-6736(22)01656-7 ] [PMID: 36244382]
[16]
Silva-Valencia J, Soto-Becerra P, Escobar-Agreda S, et al. Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data. Vaccine 2022; 40(45): 6512-9.
[http://dx.doi.org/10.1016/j.vaccine.2022.09.066 ] [PMID: 36202642]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy